International Journal of General Medicine (Oct 2021)
Evaluation and Prediction Analysis of 3- and 5-Year Survival Rates of Patients with Cecal Adenocarcinoma Based on Period Analysis
Abstract
Zi‘an Shao,1,2,* Shuai Zheng,3,* Chong Chen,3 Jun Lyu2 1The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China; 2Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, People’s Republic of China; 3School of Public Health, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun LyuDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People’s Republic of ChinaTel +86-13379060167Email [email protected]: Cecal adenocarcinoma has a high degree of malignancy and poor prognosis, thereby bringing serious disease burden to patients. The long-term survival rate of patients with cecal adenocarcinoma deserves us to explore more deeply. In addition, appropriate methods that evaluate the survival outcome of cecal adenocarcinoma are few.Methods: This study used the data provided by the Surveillance, Epidemiology, and End Results (SEER) database to evaluate and predict the survival rates of patients with cecal adenocarcinoma from 2002 to 2016 and from 2017 to 2021, respectively. The cohort of population taken are all older than 20 years old, which is from National Cancer Institute. The period analysis was used to check the data in the SEER database. Reliable results could be obtained using period analysis, which provided important information for prevention and treatment strategies.Results: From 2002 to 2016, the relative survival rate of patients with cecal adenocarcinoma increased yearly. Compared with those in previous 15 years, the relative survival rate between 2017 and 2021 still increased but to a low extent. The relative survival rates of patients with cecal adenocarcinoma were remarkably different in terms of age, sex, race, differentiation grade, stages, and socioeconomic status. Even if there is a significant improvement, the survival rate of patients with distant-stage cancer is at a very low level.Conclusion: Understanding the survival rate of patients with cecal adenocarcinoma in the past 15 years is helpful in predicting the future trend and providing basic data and scientific basis to evaluate the harm of cecal adenocarcinoma to patients’ health, prepare cancer prevention plans, and evaluate the effect of cancer prevention and treatment by exploring the differences in survival rate corresponding to different ages, sexes, races, differentiation grades, stages, and socioeconomic status.Keywords: cecal adenocarcinoma, SEER, period analysis, survival rates
